Safety and efficacy of oral transmucosal fentanyl citrate for prehospital pain control on the battlefield

被引:44
作者
Wedmore, Ian S. [2 ]
Kotwal, Russ S. [1 ]
McManus, John G. [3 ]
Pennardt, Andre [1 ]
Talbot, Timothy S. [1 ]
Fowler, Marcie [4 ]
McGhee, Laura [4 ]
机构
[1] USA, Special Operat Command, Ft Bragg, NC 28310 USA
[2] Joint Base Lewis McChord, Madigan Army Med Ctr, Washington, DC USA
[3] Army Med Dept Ctr & Sch, Emergency Med Serv, Ft Sam Houston, TX USA
[4] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA
关键词
Acute pain; prehospital analgesia; battlefield; oral transmucosal fentanyl citrate; pain management; BREAKTHROUGH CANCER PAIN; COMBAT CASUALTY CARE; RANDOMIZED CLINICAL-TRIAL; INTRAVENOUS MORPHINE; EMERGENCY-MEDICINE; OPEN-LABEL; POSTOPERATIVE PAIN; LACERATION REPAIR; CASE SERIES; MANAGEMENT;
D O I
10.1097/TA.0b013e3182754674
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Acute pain, resulting from trauma and other causes, is a common condition that imposes a need for prehospital analgesia on and off the battlefield. The narcotic most frequently used for prehospital analgesia on the battlefield during the past century has been morphine. Intramuscular morphine has a delayed onset of pain relief that is suboptimal and difficult to titrate. Although intravenously administered morphine can readily provide rapid and effective prehospital analgesia, oral transmucosal fentanyl citrate (OTFC) is a safe alternative that does not require intravenous access. This study evaluates the safety and efficacy of OTFC in the prehospital battlefield environment. METHODS: Data collected during combat deployments (Afghanistan and Iraq) from March 15, 2003, to March 31, 2010, were analyzed. Patients were US Army Special Operations Command casualties. Patients receiving OTFC for acute pain were evaluated. Pretreatment and posttreatment pain intensities were quantified by the verbal numeric rating scale (NRS) from 0 to 10. OTFC adverse effects and injuries treated were also evaluated. RESULTS: A total of 286 patients were administered OTFC, of whom 197 had NRS pain evaluations conducted before and approximately 15 minutes to 30 minutes following treatment. The difference between NRS pain scores at 0 minutes (NRS, 8.0 [1.4]) and 15 minutes to 30 minutes (NRS, 3.2 [2.1]) was significant (p < 0.001). Only 18.3% (36 of 197) of patients were also administered other types of analgesics. Nausea was the most common adverse effect as reported by 12.7% (25 of 197) of patients. The only major adverse effect occurred in the patient who received the largest opioid dose, 3,200-mu g OTFC and 20-mg morphine. This patient exhibited hypoventilation and saturation of less than 90% requiring low-dose naloxone. CONCLUSION: OTFC is a rapid and noninvasive pain management strategy that provides safe and effective analgesia in the prehospital battlefield setting. OTFC has considerable implications for use in civilian prehospital and austere environments. (J Trauma Acute Care Surg. 2012;73: S490-S495. Copyright (C) 2012 by Lippincott Williams & Wilkins)
引用
收藏
页码:S490 / S495
页数:6
相关论文
共 50 条
[1]  
ASHBURN MA, 1993, ANESTH ANALG, V76, P377
[2]   ORAL TRANSMUCOSAL FENTANYL CITRATE FOR PREMEDICATION IN PEDIATRIC OUTPATIENTS [J].
ASHBURN, MA ;
STREISAND, JB ;
TARVER, SD ;
MEARS, SL ;
MULDER, SM ;
FLOET, AW ;
LUIJENDIJK, RW ;
ELWYN, RA ;
PACE, NL ;
STANLEY, TH .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1990, 37 (08) :857-866
[3]   PAIN IN MEN WOUNDED IN BATTLE [J].
BEECHER, HK .
ANNALS OF SURGERY, 1946, 123 (01) :96-105
[4]  
Bredahl Claus, 2005, Ugeskr Laeger, V167, P2289
[5]   Pain Following Battlefield Injury and Evacuation: A Survey of 110 Casualties from the Wars in Iraq and Afghanistan [J].
Buckenmaier, Chester C., III ;
Rupprecht, Christine ;
McKnight, Geselle ;
McMillan, Brian ;
White, Ronald L. ;
Gallagher, Rollin M. ;
Polomano, Rosemary .
PAIN MEDICINE, 2009, 10 (08) :1487-1496
[6]   Tactical combat casualty care in special operations [J].
Butler, FK ;
Hagmann, J ;
Butler, EG .
MILITARY MEDICINE, 1996, 161 :3-16
[7]  
Butler FK, 2007, MIL MED, V172, P1
[8]   Breakthrough cancer pain:: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®) [J].
Coluzzi, PH ;
Schwartzberg, L ;
Conroy, JD ;
Charapata, S ;
Gay, M ;
Busch, MA ;
Chavez, J ;
Ashley, J ;
Lebo, D ;
McCracken, M ;
Portenoy, RK .
PAIN, 2001, 91 (1-2) :123-130
[9]   A fentanyl-based pain management protocol provides early analgesia for adult trauma patients [J].
Curtis, Kevin M. ;
Henriques, Horace F. ;
Fanciullo, Gilbert ;
Reynolds, Cecily M. ;
Suber, Freeman .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2007, 63 (04) :819-826
[10]   Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate [J].
Darwish, Mona ;
Kirby, Mary ;
Robertson, Philmore, Jr. ;
Tracewell, William ;
Jiang, John G. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (03) :343-350